MedPharm is a specialist pharmaceutical development company that is recognised internationally for its expertise in transdermal and topical (skin, nail, nose, lungs and other mucosal membranes) drug delivery systems and formulations. Established in 1999, and with numerous high profile customers, MedPharm has built a worldwide reputation for its unique and highly specialised service in contract research and development; together with expert project management. Projects range from simple feasibility tests, formulation and dosage form design and optimisation, through to preparation of GMP clinical supplies for Phase I/II trials with guaranteed subsequent smooth transfer through to commercial manufacturing sites. The company operates a hybrid business model, with a CRO business and a development programme with a substantial patent portfolio of novel topical and transdermal drug delivery systems. These systems include MedSpray®, MedTherm® and AquaRMed™. It has produced these innovations by exploiting its internal product development expertise, with a particular focus on dermatology. The company is actively seeking to license these technologies to third parties for developing with their own compounds in non-competing indications. MedPharm’s laboratories in the UK are routinely inspected by Regulatory Authorities to ensure that its Quality System meets the requirements for GMP and GLP.